We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current EWTX market cap is 2.63B. The company's latest EPS is USD -1.0578 and P/E is -26.31.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.45M | -33.86M | -34.75M | -38.11M | -40.43M |
| Net Income | -25.71M | -30.14M | -28.53M | -31.5M | -34.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.92M | -17.19M | -43.22M | -71.66M | -114.36M |
| Net Income | -9.71M | -17.12M | -42.81M | -67.64M | -100.16M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 311.36M | 340.04M | 553.81M | 531.65M | 511.28M |
| Total Liabilities | 20.94M | 21.21M | 18.87M | 21.17M | 22.41M |
| Total Equity | 290.43M | 318.83M | 534.94M | 510.47M | 488.88M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.54M | 131.14M | 285.23M | 367.1M | 340.04M |
| Total Liabilities | 1.13M | 4.34M | 10.85M | 20.39M | 21.21M |
| Total Equity | -16.85M | -33.42M | 274.38M | 346.72M | 318.83M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -65.12M | -91.95M | -28.6M | -54.7M | -82.07M |
| Investing | 75.9M | 102.89M | -268.31M | -230.94M | -205.58M |
| Financing | 179k | 53.17M | 241.07M | 243.03M | 246.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.17M | -14.63M | -33.51M | -52.64M | -91.95M |
| Investing | -180k | -24.38M | -242.23M | -70.58M | 102.89M |
| Financing | 24.8M | 120.28M | 186.38M | 129.64M | 53.17M |
| Market Cap | 2.63B |
| Price to Earnings Ratio | -26.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 30.61 |
| Price to Book Ratio | 8.27 |
| Dividend Yield | - |
| Shares Outstanding | 94.69M |
| Average Volume (1 week) | 1.12M |
| Average Volume (1 Month) | 997.61k |
| 52 Week Change | 68.59% |
| 52 Week High | 38.12 |
| 52 Week Low | 14.75 |
| Spread (Intraday) | 2.13 (7.31%) |
| Company Name | Edgewise Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.edgewisetx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
